These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 4502507

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Letter: Acute lymphoid leukemia: constant induction of remission by the combination of prednisone, vincristine and L-asparaginase (20 cases)].
    Mathe G, Pouillart P, De Vassal F, Delgado M, Schwarzenberg L, Misset JL, Hayat M, Jasmin C, Belpomme D, Musset M.
    Nouv Presse Med; 1976 Jun 05; 5(23):1491. PubMed ID: 1064849
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Comparison of CNS-leukaemia in children with acute leukaemia, induced either with rubidomycin or L-asparaginase.
    de Vaan GA, Marcar JR, Schretlen ED.
    Padiatr Padol; 1971 Jun 05; 6(3):230-9. PubMed ID: 5293526
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The treatment of acute leukemia.
    Haskell CM, Cline MJ.
    Ration Drug Ther; 1974 Oct 05; 8(10):1-7. PubMed ID: 4529560
    [No Abstract] [Full Text] [Related]

  • 11. Favorable remission induction rate with twice weekly doses of L-asparaginase.
    Jaffe N, Traggis D, Das L, Frauenberger G, Hann HW, Kim BS, Bishop Y.
    Cancer Res; 1973 Jan 05; 33(1):1-4. PubMed ID: 4565907
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Optimal use of L-asparaginase (NSC-109229) in acute lymphocytic leukemia.
    Jones B, Holland JF, Glidewell O, Jacquillat C, Weil M, Pochedly C, Sinks L, Chevalier L, Maurer HM, Koch K, Falkson G, Patterson R, Seligman B, Sartorius J, Kung F, Haurani F, Stuart M, Burgert EO, Ruymann F, Sawitsky A, Forman E, Pluess H, Truman J, Hakami N.
    Med Pediatr Oncol; 1977 Jan 05; 3(4):387-400. PubMed ID: 337095
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Selective deficiency in collagen-induced platelet aggregation during L-asparaginase therapy.
    Shapiro RS, Gerrard JM, Ramsay NK, Nesbit ME, Coccia PF, Stoddard SF, Plow EF, White JG, Krivit W.
    Am J Pediatr Hematol Oncol; 1980 Jan 05; 2(3):207-12. PubMed ID: 6933865
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Preliminary observations on sequential therapy with daunorubicin and L-asparaginase in acute lymphoblastic leukemia].
    Masera G, Carnelli V, Bollina A.
    Minerva Med; 1972 Mar 31; 63(24):1457-8. PubMed ID: 4502508
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.